)

Rapid Micro Biosystems (RPID) investor relations material
Rapid Micro Biosystems H.C. Wainwright 27th Annual Global Investment Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Key business highlights
Focused on modernizing microbial quality control in pharmaceutical manufacturing with automated technology, replacing outdated manual methods and emphasizing data integrity.
Achieved $28M in 2024 revenue with 25% year-over-year growth, over $15M from recurring sources; installed 170+ systems globally, 150+ validated across 20 countries.
Present in 75% of top 20 global biopharma companies and 86% of approved CAR T manufacturers, with a CAGR of 28% over recent years.
Targeting 25–30% average revenue growth through 2027 and aiming for 50% gross margins by 2027, supported by margin expansion initiatives.
Partnership with Merck KGaA (MilliporeSigma) enables broader distribution, supply chain synergies, and joint innovation, supporting growth and margin goals.
Technology and value proposition
Growth Direct platform automates microbial testing, integrates with lab management systems, and is 21 CFR 11 compliant for data integrity and regulatory compliance.
Reduces manual labor, accelerates contamination detection, shortens product release cycles, and delivers 50% faster results.
Large addressable market estimated at over $10B, driven by regulatory scrutiny and demand for complex therapies.
Expansion into adjacent markets like personal care, medical devices, cosmetics, and food & beverage, leveraging Merck’s sales force.
Strong barriers to entry with first-mover advantage, robust patent portfolio, and low competitive intensity.
Growth strategy and market position
Growth driven by acquiring new customers, expanding within existing accounts, launching new products/services, and global deployments.
Recurring revenue model with high yield per system; over 50% of revenue is recurring and expected to increase.
Strong presence in Europe and North America, with growing traction in Asia.
Thousands of potential sites remain untapped, with opportunities across biologics, cell and gene, CDMO, and small molecule segments.
Emphasis on automation, data services, AI, and SaaS to drive future growth.
Next Rapid Micro Biosystems earnings date

Next Rapid Micro Biosystems earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage